GlassScriptPhysician profile
Matthew T Smith
NPI 1144541152
$13,110.22
in general payments reported to CMS, 2019-2025
21 companies · $3,209 in 2025
The $3,209 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,246 · 2020: $300 · 2021: $560 · 2022: $289 · 2023: $1,290 · 2024: $217 · 2025: $3,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,490 · Food and Beverage: $1,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,490.22 |
| Food and Beverage | $1,224.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,248.28 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $170.64 | 2022-2025 | |
| Integra Lifesciences Corporation | $92.12 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $87.51 | 2024 | Inhance |
| Stryker Corporation | $77.77 | 2022 | |
| Medtronic, INC. | $57.72 | 2022-2023 | Progrip |
| Vertex Pharmaceuticals Incorporated | $45.00 | 2025 | |
| Innocoll Pharmaceuticals Limited | $34.62 | 2021-2022 | |
| Davol INC. | $33.15 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.64 | 2024 | Gattex |
| Boston Scientific Corporation | $31.57 | 2025 | General - Pain Management |
| Redhill Biopharma INC. | $29.82 | 2021-2022 | |
| Heron Therapeutics, INC. | $23.22 | 2022 | |
| Protega Pharmaceutials INC | $22.54 | 2023 | Roxybond |
| Smith+Nephew, INC. | $21.51 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $21.47 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, Activ.A.C. |
| Lsi Solutions INC | $21.13 | 2023 | Running Device, Ti Knot |
| Aroa Biosurgery Incorporated | $17.28 | 2022 | |
| Kci USA, INC. | $16.57 | 2022 | |
| Innovation Technologies INC | $14.13 | 2025 | Irrisept |
| Focal Therapeutics, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.